Unlock stock picks and a broker-level newsfeed that powers Wall Street.

BSE - Delayed Quote INR

Bliss GVS Pharma Limited (BLISSGVS.BO)

122.05
-4.25
(-3.37%)
At close: April 25 at 3:40:31 PM GMT+5:30
Currency in INR All numbers in thousands
Breakdown
TTM
3/31/2024
3/31/2023
3/31/2022
3/31/2021
Total Revenue
8,055,314
7,659,076
7,474,287
7,379,285
5,686,875
Cost of Revenue
4,097,279
3,821,157
4,013,249
3,909,820
3,297,188
Gross Profit
3,958,035
3,837,919
3,461,038
3,469,465
2,389,687
Operating Expense
2,795,724
2,490,349
2,453,706
2,288,020
1,479,721
Operating Income
1,162,311
1,347,570
1,007,332
1,181,445
909,966
Net Non Operating Interest Income Expense
39,842
53,673
37,592
48,390
23,359
Pretax Income
982,501
1,168,720
1,060,716
541,653
1,041,270
Tax Provision
295,609
352,941
293,368
310,388
301,554
Net Income Common Stockholders
596,125
754,541
708,588
150,402
684,909
Diluted NI Available to Com Stockholders
596,125
754,541
708,588
150,402
684,909
Basic EPS
5.67
7.23
6.83
1.46
6.64
Diluted EPS
5.63
7.11
6.72
1.43
6.49
Basic Average Shares
104,808.88
104,314.24
103,805.63
103,335.82
103,146.67
Diluted Average Shares
105,919.94
106,071.74
105,478.88
105,201.07
105,477.67
Rent Expense Supplemental
--
16,499
19,021
15,632
8,592
Total Expenses
6,893,003
6,311,506
6,466,955
6,197,840
4,776,909
Net Income from Continuing & Discontinued Operation
596,125
754,541
708,588
150,402
684,909
Normalized Income
866,772.06
1,024,756.28
721,022.94
783,986.70
696,135.42
Interest Income
--
117,904
75,041
88,181
95,785
Interest Expense
69,452
55,621
32,444
29,295
60,297
Net Interest Income
39,842
53,673
37,592
48,390
23,359
EBIT
1,051,953
1,224,341
1,093,160
570,948
1,101,567
EBITDA
1,334,234
1,488,139
1,279,893
744,256
1,273,864
Reconciled Cost of Revenue
4,097,279
3,821,157
4,013,249
3,909,820
3,297,188
Reconciled Depreciation
282,281
263,798
186,733
173,308
172,297
Net Income from Continuing Operation Net Minority Interest
596,125
754,541
708,588
150,402
684,909
Total Unusual Items Excluding Goodwill
-387,122
-387,122
-17,189
-905,121
-15,803
Total Unusual Items
-387,122
-387,122
-17,189
-905,121
-15,803
Normalized EBITDA
1,721,356
1,875,261
1,297,082
1,649,377
1,289,667
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-116,474.94
-116,906.72
-4,754.06
-271,536.30
-4,576.58
3/31/2021 - 1/11/2002

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade